<?xml version="1.0" encoding="UTF-8"?>
<feed xmlns="http://www.w3.org/2005/Atom" xmlns:dc="http://purl.org/dc/elements/1.1/">
  <title>DSpace Collection:</title>
  <link rel="alternate" href="http://hdl.handle.net/10451/3767" />
  <subtitle />
  <id>http://hdl.handle.net/10451/3767</id>
  <updated>2013-05-25T08:25:30Z</updated>
  <dc:date>2013-05-25T08:25:30Z</dc:date>
  <entry>
    <title>Electron Ionization Mass Spectrometric Study of Some Substituted 1,3-oxazoles</title>
    <link rel="alternate" href="http://hdl.handle.net/10451/7627" />
    <author>
      <name>Salgueiro, Pedro</name>
    </author>
    <author>
      <name>Dias, Catarina</name>
    </author>
    <author>
      <name>Carreiras, M. Carmo</name>
    </author>
    <author>
      <name>Borges, Carlos</name>
    </author>
    <id>http://hdl.handle.net/10451/7627</id>
    <updated>2013-02-01T12:10:28Z</updated>
    <published>2007-11-01T00:00:00Z</published>
    <summary type="text">Title: Electron Ionization Mass Spectrometric Study of Some Substituted 1,3-oxazoles
Authors: Salgueiro, Pedro; Dias, Catarina; Carreiras, M. Carmo; Borges, Carlos
Abstract: Heterocyclic compounds are widely used as pharmaceuticals. Tacrine (THA) was the first drug approved for the treatment of Alzheimer’s disease (AD) and a great effort has been made to design and synthesize new THA-analogues in order to evaluate their beneficial effects as therapeutic agents in this disease.1-6 Contrasting with the pharmaceutical interest, mass spectrometric studies of these compounds and of some of its precursors, namely the oxazole and oxazole derivatives, are scarce. &#xD;
In order to obtain its structural information, a mass spectrometric study was performed with some 5-amino-2-aryl-4-cyano-1,3-oxazoles (Compounds 1 - 5) using a quadrupole mass spectrometer, equipped with an electron ionization (EI) ion source. &#xD;
Detailed fragmentation pathways have been established for all significant ions, including some fragment ions characteristic of the oxazole family. &#xD;
&#xD;
&#xD;
1. Marco JL, Ríos C, Carreiras MC, Baños JE, Badía A, Vivas NM. Bioorg. Med. Chem. 2001; 9: 727.&#xD;
2. Ros E, Aleu J, Gomez de Aranda I, Canti C, Pang YP, Marsal J, Solsona C. J Neurophysiol. 2001; 86: 183.&#xD;
3. Marco JL, Ríos C, Carreiras MC, Baños JE, Badía A, Vivas NM. Arch. Pharm. Pharm. Med. Chem. 2002; 7: 347.&#xD;
4. Barreiro EJ, Câmara CA, Verli H, Brazilmás L, Castro NG, Cintra WM, Aracava Y, Rodrigues CR, Fraga CAM. Journal of Medicinal Chemistry 2003; 46: 1144.&#xD;
5. Marco JL, Carreiras MC. Mini-Rev. Med. Chem. 2003; 3: 518.&#xD;
6. Marco JL, Ríos C, García AG, Villarroya M, Carreiras MC, Martins C, Eleutério A, Morreale A, Orozco M, Luque FJ. Bioorg. Med. Chem. 2004; 12: 2199.
Description: Comunicação oral sob a forma painel</summary>
    <dc:date>2007-11-01T00:00:00Z</dc:date>
  </entry>
</feed>

